Gosuranemab (BIIB092) is a humanised monoclonal antibody targeting N-terminal tau, inhibiting the propagation and aggregation of pathological tau proteins for potential application in Alzheimers disease.
Purity:
95.00%
CAS Number:
[1788032-39-2]
Target:
Microtubule Associated
* VAT and and shipping costs not included. Errors and price changes excepted